Boston Partners’s National Vision EYE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$38.3M Buy
2,335,789
+87,895
+4% +$1.67M 0.03% 303
2026
Q2
$42.7M Buy
2,247,894
+823,951
+58% +$16.8M 0.04% 298
2026
Q1
$36.9M Sell
1,423,943
-67,528
-5% -$1.83M 0.04% 293
2025
Q4
$38.5M Buy
1,491,471
+370,484
+33% +$10M 0.04% 289
2025
Q3
$32.7M Sell
1,120,987
-14,590
-1% -$358K 0.03% 316
2025
Q2
$26.1M Sell
1,135,577
-45,753
-4% -$780K 0.03% 327
2025
Q1
$15.1M Sell
1,181,330
-26,634
-2% -$315K 0.02% 348
2024
Q4
$12.6M Buy
+1,207,964
New +$13.2M 0.02% 380

Other funds holding EYE

Boston Partners's EYE Position: Q3 2026 in Review

Boston Partners increased its National Vision (EYE) stake by 3.9% in Q3 2026, buying an estimated $1.67M and bringing the position to 2,335,789 shares worth $38.3M. The position accounts for 0.03% of the portfolio, ranked #303.

Boston Partners first reported a position in EYE in Q4 2024 and has held it in 8 quarters since. The position peaked at $42.7M in Q2 2026. 119 funds tracked by Wall St. Rank hold EYE as of Q3 2026.

  • Boston Partners held 2,335,789 shares of National Vision worth $38.3M as of Q3 2026.
  • Boston Partners bought 87,895 National Vision shares in Q3 2026, an estimated $1.67M.
  • National Vision made up 0.03% of Boston Partners's portfolio in Q3 2026, its #303 holding.
  • Boston Partners first reported a position in National Vision in Q4 2024 and has held it in 8 quarters since.
  • Boston Partners's National Vision position peaked at $42.7M in Q2 2026.
  • 119 funds tracked by Wall St. Rank held National Vision as of Q3 2026.

Based on Boston Partners's 13F filing for Q3 2026, filed 10 Nov 2026.